Ongoing Negotiations Between University of Michigan Medicine and BCBSM
The ongoing negotiations between University of Michigan Medicine and Blue Cross Blue Shield of Michigan (BCBSM) are focused on establishing new reimbursement terms. If an agreement is not reached, patients covered by Blue Cross or Blue Care Network may face out-of-network charges for certain non-emergency and non-elective procedures at University of Michigan Health System facilities starting July 1. This highlights the need for swift resolution to avoid disruption in patient care.
Continuation of In-Network Benefits
BCBSM has announced a 90-day "Continuity of Care" provision, maintaining in-network coverage for patients with severe health conditions like cancer, cardiovascular disease, and diabetes. This provision also supports pregnant women and recent organ transplant recipients, ensuring they receive continuous care. The extension is crucial for those with complex medical needs, emphasizing BCBSM's commitment to patient welfare during negotiations.
Alternative Insurance Solutions
The MSMS Physicians Insurance Agency (PIA) is diligently monitoring the situation and preparing to offer alternative insurance solutions should the negotiations stall. Individuals and groups can contact Angela Criswell, Director of Operations and Sales, for assistance at 517-336-5734 or acriswell@msms.org. PIA specializes in insurance products tailored for Michigan healthcare professionals and their affiliations.
Credentialing and Enrollment Services
PCVS provides essential credentialing, primary source verification, and provider enrollment services to healthcare entities, leveraging physician reviews to enhance patient safety and clinical education. These efforts contribute significantly to the overall quality of care within the healthcare system.
Political Engagement
A bipartisan political action committee, composed of healthcare professionals and stakeholders, actively advocates for improvements within the medical sector. Through informed political involvement, the committee strives for advancements that benefit both patients and providers, ensuring the healthcare industry's progression aligns with regulatory and quality standards.